CMS' semaglutide coverage expansion could save millions of livesA group of 44 health care and advocacy organizations is urging the Centers for Medicare & Medicaid Services (CMS) to expand coverage and...
Price of anti-obesity medications limits access for those most in needRecent results from clinical trials and studies assessing anti-obesity medications, in addition regulatory approvals, has resulted in...
ECRI report identifies reasons weight loss drugs have been underutilisedECRI, the largest non-profit patient safety organisation in the US, is calling on healthcare leaders to change their approach and fully...
LSG and RYGB-induced upregulation of apoA-IV is beneficial for insulin secretion and energy expenditure5 days ago
Tirzepatide reduced sleep apnoea severity by up to nearly two-thirds in adults living with OSA and obesity5 days ago